Dong-A Pharmaceutical Co., Ltd. Sustainability Profile
Dong-A Pharmaceutical Co., Ltd., a prominent player in the pharmaceutical industry, is headquartered in South Korea (KR) and has established a significant presence across various operational regions. Founded in 1932, the company has achieved numerous milestones, positioning itself as a leader in the development and manufacturing of innovative healthcare solutions. Specialising in prescription medications, over-the-counter products, and biopharmaceuticals, Dong-A is renowned for its commitment to quality and research-driven approaches. Its core offerings include a diverse range of therapeutic areas, particularly in pain management and infectious diseases, which set it apart in a competitive market. With a strong emphasis on research and development, Dong-A Pharmaceutical has garnered recognition for its contributions to healthcare, solidifying its market position as a trusted provider of effective and safe pharmaceutical products.
DitchCarbon Score
How does Dong-A Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Dong-A Pharmaceutical Co., Ltd.'s score of 41 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Dong-A Pharmaceutical Co., Ltd., headquartered in South Korea (KR), currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of Dong-A Socio Holdings Co., Ltd., which may influence its climate-related initiatives and commitments. While there are no documented reduction targets or specific climate pledges from Dong-A Pharmaceutical, it is important to note that emissions data and performance metrics may be inherited from its parent company. The climate commitments and strategies of Dong-A Socio Holdings Co., Ltd. could provide context for Dong-A Pharmaceutical's environmental approach, although specific details are not disclosed. As a participant in the pharmaceutical industry, Dong-A Pharmaceutical is likely to be aware of the growing emphasis on sustainability and carbon reduction within the sector. However, without explicit data or commitments, the company's current stance on carbon emissions remains unclear.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 152,000 | 000,000 | 000,000 |
| Scope 2 | 291,000 | 000,000 | 000,000 |
| Scope 3 | 47,000 | 00,000 | 000,000 |
How Carbon Intensive is Dong-A Pharmaceutical Co., Ltd.'s Industry?
How Carbon Intensive is Dong-A Pharmaceutical Co., Ltd.'s Location?
Dong-A Pharmaceutical Co., Ltd.'s Scope 3 Categories Breakdown
Dong-A Pharmaceutical Co., Ltd.'s Scope 3 emissions, which increased by 157% last year and increased by approximately 196% since 2022, demonstrating supply chain emissions tracking. Their carbon footprint includes suppliers and value chain emissions, with Scope 3 emissions accounting for 22% of total emissions under the GHG Protocol, with "Fuel and Energy Related Activities" being the largest emissions source at 44% of Scope 3 emissions.
Top Scope 3 Categories
Dong-A Pharmaceutical Co., Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Dong-A Pharmaceutical Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.